Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(6.50) per share which missed the analyst consensus estimate of $(6.07) by 7.08 percent. This is a 83.22 percent increase over losses of $(38.73) per share from the same period last year.